Early detection of gastric cancer using DNA features in red blood cells, with multicenter validation.
Blood tests detect early gastric cancer with 83–90% sensitivity across multiple hospitals, suggesting practical screening potential.
This diagnostic validation study examined Early detection of gastric cancer using DNA features in red blood cells, with multicenter validation. The abstract reports that Across three hospital-based multicenter validation cohorts, performance remained consistent, with 83%-90% overall sensitivity and 82%-89% sensitivity for stage I GC.
What the study was
- Study design
- Diagnostic validation study
- Population
- Human participants
- Category
- Early Detection
- Maturity
- Validated
- Journal
- Med
Why it surfaced
Diagnostic validation study; directly matches Early cancer detection, Precision oncology and genomic medicine. Conservative abstract-level score 8/10.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.